AU2002319613A1 - Human tissue specific drug screening procedure - Google Patents
Human tissue specific drug screening procedureInfo
- Publication number
- AU2002319613A1 AU2002319613A1 AU2002319613A AU2002319613A AU2002319613A1 AU 2002319613 A1 AU2002319613 A1 AU 2002319613A1 AU 2002319613 A AU2002319613 A AU 2002319613A AU 2002319613 A AU2002319613 A AU 2002319613A AU 2002319613 A1 AU2002319613 A1 AU 2002319613A1
- Authority
- AU
- Australia
- Prior art keywords
- human tissue
- tissue specific
- drug screening
- specific drug
- screening procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000007877 drug screening Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/10—Oligonucleotides as tagging agents for labelling antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30706201P | 2001-07-19 | 2001-07-19 | |
| US60/307,062 | 2001-07-19 | ||
| PCT/US2002/023138 WO2003008968A2 (en) | 2001-07-19 | 2002-07-18 | Human tissue specific drug screening procedure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002319613A1 true AU2002319613A1 (en) | 2003-03-03 |
Family
ID=23188077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002319613A Abandoned AU2002319613A1 (en) | 2001-07-19 | 2002-07-18 | Human tissue specific drug screening procedure |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20040241688A1 (en) |
| AU (1) | AU2002319613A1 (en) |
| WO (2) | WO2003008968A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104011537A (en) * | 2011-07-14 | 2014-08-27 | 德加尔电系统公司 | Electrophoresis buffer for extending the useful electrophoresis life of an electrophoresis gel |
Families Citing this family (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003076649A1 (en) * | 2002-03-05 | 2003-09-18 | Aclara Biosciences, Inc. | Multiplex analysis using membrane-bound sensitizers |
| ES2217931B1 (en) * | 2002-07-01 | 2006-02-16 | Universidad De Barcelona | METHOD OF DIAGNOSIS OF THE EVOLUTION OF THE INTESTINAL ABSORTIVE MASS IN AN INDIVIDUAL. |
| WO2005026387A1 (en) | 2003-09-18 | 2005-03-24 | Nuevolution A/S | A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
| US7608549B2 (en) * | 2005-03-15 | 2009-10-27 | Asm America, Inc. | Method of forming non-conformal layers |
| US11237171B2 (en) | 2006-02-21 | 2022-02-01 | Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
| US8492098B2 (en) | 2006-02-21 | 2013-07-23 | The Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of reaction components that affect a reaction |
| US8131476B2 (en) * | 2006-08-07 | 2012-03-06 | General Electric Company | System and method for co-registering multi-channel images of a tissue micro array |
| US20080032321A1 (en) * | 2006-08-07 | 2008-02-07 | General Electric Company | System and methods for analyzing images of tissue samples |
| US8060348B2 (en) * | 2006-08-07 | 2011-11-15 | General Electric Company | Systems for analyzing tissue samples |
| US7629125B2 (en) * | 2006-11-16 | 2009-12-08 | General Electric Company | Sequential analysis of biological samples |
| US9201063B2 (en) * | 2006-11-16 | 2015-12-01 | General Electric Company | Sequential analysis of biological samples |
| US7741045B2 (en) * | 2006-11-16 | 2010-06-22 | General Electric Company | Sequential analysis of biological samples |
| WO2009029073A1 (en) | 2007-08-30 | 2009-03-05 | The Trustees Of Tufts College | Methods for determining the concentration of an analyte in solution. |
| US10416162B2 (en) | 2007-12-20 | 2019-09-17 | Monogram Biosciences, Inc. | Her2 diagnostic methods |
| US20090298088A1 (en) * | 2008-05-30 | 2009-12-03 | Belyaev Alexander S | Cleavable catalytic binding and detection system |
| US20100075439A1 (en) * | 2008-09-23 | 2010-03-25 | Quanterix Corporation | Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification |
| US8222047B2 (en) * | 2008-09-23 | 2012-07-17 | Quanterix Corporation | Ultra-sensitive detection of molecules on single molecule arrays |
| ES2637411T3 (en) | 2008-12-01 | 2017-10-13 | Laboratory Corporation Of America Holdings | Methods and assays for measuring p95 Y / O p95 in a sample and antibodies specific for p95 |
| BRPI1007048A2 (en) * | 2009-01-15 | 2016-02-10 | Lab Corp America Holdings | method and kit for correlating the relative levels of the amount of at least one her-2 or her-2 homodimers in a biological sample from an individual, and method for predicting whether an individual with cancer and who is treated with an agent that acts on her-2 is likely to have a significant event. |
| WO2010083470A1 (en) | 2009-01-15 | 2010-07-22 | Laboratory Corporation Of America Holdings | Methods of determining patient response by measurement of her-3 |
| US9677125B2 (en) * | 2009-10-21 | 2017-06-13 | General Electric Company | Detection of plurality of targets in biological samples |
| US8415171B2 (en) | 2010-03-01 | 2013-04-09 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| US9678068B2 (en) * | 2010-03-01 | 2017-06-13 | Quanterix Corporation | Ultra-sensitive detection of molecules using dual detection methods |
| JP5363663B2 (en) * | 2010-03-01 | 2013-12-11 | クワンテリクス コーポレーション | Method or system for extending the dynamic range in an assay to detect molecules or particles |
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
| KR101866401B1 (en) | 2010-04-05 | 2018-06-11 | 프로그노시스 바이오사이언스, 인코포레이티드 | Spatially encoded biological assays |
| US8685649B2 (en) * | 2010-06-10 | 2014-04-01 | The United States Of America As Represented By The Secretary Of The Navy | RT-LAMP assay for the detection of pan-serotype dengue virus |
| JP5978220B2 (en) | 2010-10-29 | 2016-08-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Nucleic acid nanostructure barcode probe |
| US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
| WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| CN102796094B (en) * | 2011-05-24 | 2015-04-15 | 华东理工大学 | Dihalofluorescein derivative and application thereof |
| EP3511423B2 (en) | 2012-10-17 | 2024-05-29 | Spatial Transcriptomics AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| US9932626B2 (en) | 2013-01-15 | 2018-04-03 | Quanterix Corporation | Detection of DNA or RNA using single molecule arrays and other techniques |
| US10125385B2 (en) * | 2013-02-25 | 2018-11-13 | Pdl Biopharma, Inc. | Electrochemiluminescence (ECL) detection reagents and related methods for measuring enzyme activity |
| US9868979B2 (en) | 2013-06-25 | 2018-01-16 | Prognosys Biosciences, Inc. | Spatially encoded biological assays using a microfluidic device |
| CN105531377A (en) | 2013-07-30 | 2016-04-27 | 哈佛学院院长及董事 | DNA-based quantitative imaging and super-resolution imaging |
| KR102313982B1 (en) | 2014-03-11 | 2021-10-18 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | High-throughput and highly multiplexed imaging with programmable nucleic acid probes |
| ES2955488T3 (en) | 2015-04-10 | 2023-12-01 | Spatial Transcriptomics Ab | Multiplex analysis of biological specimens of spatially distinguished nucleic acids |
| KR102557419B1 (en) | 2015-08-07 | 2023-07-19 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Super-resolution imaging of protein-protein interactions |
| US20180164308A1 (en) | 2016-12-09 | 2018-06-14 | Ultivue, Inc. | Methods for multiplex imaging using labeled nucleic acid imaging agents |
| EP3769083A1 (en) | 2018-03-21 | 2021-01-27 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbents, devices and methods |
| US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
| EP3894592A2 (en) | 2018-12-10 | 2021-10-20 | 10X Genomics, Inc. | Generating spatial arrays with gradients |
| US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| WO2020243579A1 (en) | 2019-05-30 | 2020-12-03 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| EP4025711A2 (en) | 2019-11-08 | 2022-07-13 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
| EP3891300B1 (en) | 2019-12-23 | 2023-03-29 | 10X Genomics, Inc. | Methods for spatial analysis using rna-templated ligation |
| US12241890B2 (en) | 2019-12-23 | 2025-03-04 | 10X Genomics, Inc. | Methods for generating barcoded nucleic acid molecules using fixed cells |
| US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
| US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
| US20210230681A1 (en) | 2020-01-24 | 2021-07-29 | 10X Genomics, Inc. | Methods for spatial analysis using proximity ligation |
| US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
| US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
| US12110541B2 (en) | 2020-02-03 | 2024-10-08 | 10X Genomics, Inc. | Methods for preparing high-resolution spatial arrays |
| US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
| US12129516B2 (en) | 2020-02-07 | 2024-10-29 | 10X Genomics, Inc. | Quantitative and automated permeabilization performance evaluation for spatial transcriptomics |
| US12281357B1 (en) | 2020-02-14 | 2025-04-22 | 10X Genomics, Inc. | In situ spatial barcoding |
| US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
| EP4242325B1 (en) | 2020-04-22 | 2025-01-29 | 10X Genomics, Inc. | Methods for spatial analysis using targeted rna depletion |
| AU2021275906A1 (en) | 2020-05-22 | 2022-12-22 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
| EP4153775B1 (en) | 2020-05-22 | 2024-07-24 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
| WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
| US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
| WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
| ES2999535T3 (en) | 2020-06-10 | 2025-02-26 | 10X Genomics Inc | Methods for determining a location of an analyte in a biological sample |
| WO2021263111A1 (en) | 2020-06-25 | 2021-12-30 | 10X Genomics, Inc. | Spatial analysis of dna methylation |
| US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
| US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
| US12209280B1 (en) | 2020-07-06 | 2025-01-28 | 10X Genomics, Inc. | Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis |
| US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
| US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
| WO2022133108A2 (en) * | 2020-12-17 | 2022-06-23 | Mammoth Biosciences, Inc. | Methods and compositions for performing a detection assay |
| EP4121555A1 (en) | 2020-12-21 | 2023-01-25 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
| WO2022221425A1 (en) | 2021-04-14 | 2022-10-20 | 10X Genomics, Inc. | Methods of measuring mislocalization of an analyte |
| WO2022256503A1 (en) | 2021-06-03 | 2022-12-08 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
| ES3011462T3 (en) | 2021-09-01 | 2025-04-07 | 10X Genomics Inc | Methods for blocking a capture probe on a spatial array |
| WO2023086880A1 (en) | 2021-11-10 | 2023-05-19 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of an analyte in a biological sample |
| EP4305195A2 (en) | 2021-12-01 | 2024-01-17 | 10X Genomics, Inc. | Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE427505B (en) * | 1977-03-04 | 1983-04-11 | Pharmacia Diagnostics Ab | REAGENT USE FOR IMMUNKEMIC DETERMINATION METHODS |
| SE404553B (en) * | 1977-03-04 | 1978-10-09 | Pharmacia Diagnostics Ab | PUTTING DETERMINATION METHODS INVOLVING BIOSPECIFIC AFFINITY REACTIONS |
| IE54109B1 (en) * | 1982-02-10 | 1989-06-21 | Boots Celltech Diagnostics | Assay |
| US4780421A (en) * | 1986-04-03 | 1988-10-25 | Sclavo Inc. | Cleavable labels for use in binding assays |
| US4965195A (en) * | 1987-10-26 | 1990-10-23 | Immunex Corp. | Interleukin-7 |
| US5417970A (en) * | 1988-10-21 | 1995-05-23 | Sanofi | Drugs containing a glycosylated interleukin-2 |
| JP3441763B2 (en) * | 1993-06-30 | 2003-09-02 | キリン−アムジエン・インコーポレーテツド | Monoclonal antibody and method for measuring human G-CSF using the monoclonal antibody |
| US5728581A (en) * | 1995-06-07 | 1998-03-17 | Systemix, Inc. | Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
| US5622699A (en) * | 1995-09-11 | 1997-04-22 | La Jolla Cancer Research Foundation | Method of identifying molecules that home to a selected organ in vivo |
| EP0987275B1 (en) * | 1995-09-11 | 2008-01-02 | La Jolla Cancer Research Foundation | Molecules that home to a selected organ or tissue in vivo |
| EP0934526B1 (en) * | 1996-10-08 | 2003-01-08 | U-BISys B.V. | Methods and means for selecting peptides and proteins having specific affinity for a target |
| DE69735445T2 (en) * | 1996-12-10 | 2006-08-10 | Sequenom, Inc., San Diego | NON-VOLATILE, NON-VOLATILE MOLECULES FOR MASS MARKING |
| US6562567B2 (en) * | 1998-01-27 | 2003-05-13 | California Institute Of Technology | Method of detecting a nucleic acid |
| WO2002030561A2 (en) * | 2000-10-10 | 2002-04-18 | Biotrove, Inc. | Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
-
2002
- 2002-07-18 WO PCT/US2002/023138 patent/WO2003008968A2/en not_active Application Discontinuation
- 2002-07-18 AU AU2002319613A patent/AU2002319613A1/en not_active Abandoned
- 2002-07-18 US US10/484,286 patent/US20040241688A1/en not_active Abandoned
- 2002-07-19 US US10/484,220 patent/US20040248325A1/en not_active Abandoned
- 2002-07-19 WO PCT/US2002/023137 patent/WO2003008972A2/en not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104011537A (en) * | 2011-07-14 | 2014-08-27 | 德加尔电系统公司 | Electrophoresis buffer for extending the useful electrophoresis life of an electrophoresis gel |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003008972A2 (en) | 2003-01-30 |
| WO2003008972A3 (en) | 2003-11-20 |
| US20040248325A1 (en) | 2004-12-09 |
| US20040241688A1 (en) | 2004-12-02 |
| WO2003008968A2 (en) | 2003-01-30 |
| WO2003008968A3 (en) | 2003-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002319613A1 (en) | Human tissue specific drug screening procedure | |
| AU2003254553A1 (en) | Medical implant | |
| AU2003253106A1 (en) | Medical implant | |
| AU2003243150A1 (en) | Resorption-controllable medical implants | |
| AU2003232258A1 (en) | Medical implant | |
| GB0106588D0 (en) | Tissue distracter | |
| AU2002321888A1 (en) | Medical needle | |
| AU2003282485A1 (en) | Implantable tissue constriction device | |
| AU2002320614A1 (en) | Methods and devices for tissue reconfiguration | |
| AU2003234088A1 (en) | Organism tissue suturing apparatus | |
| AU2003276967A1 (en) | Microsurgical tissue treatment system | |
| AU2002341931A1 (en) | Patient directed therapy management | |
| AU2001254786A1 (en) | Medical implant | |
| AU2003258298A1 (en) | Medical implants | |
| AU2003296379A1 (en) | Methods and devices for cardiac surgery | |
| IL160998A0 (en) | Human tissue factor antibodies | |
| AU2003239361A1 (en) | Customization of medical device | |
| AU2003263506A1 (en) | Medical examination system | |
| AU2001247841A1 (en) | Medical procedure | |
| AU2002336736A1 (en) | Bio-compatible medical adhesive composition | |
| AU2002319286A1 (en) | Skin treatment | |
| AU2002321019A1 (en) | Bone implant | |
| AU2001294861A1 (en) | Resorbable prosthesis for medical treatment | |
| AU2003287016A1 (en) | Human sarcoma-associated antigens | |
| AU2003904303A0 (en) | Nerve function and tissue healing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |